CRISPR Therapeutics stock price history and statistics
CRISPR Therapeutics AG · end-of-day data as of Nov 13, 2026
- PT$72.45 +71.5%
- ConsensusBuy · 23
- Bollingerbelow lower
- Sector▲ +15.9%
- Earnings in90d
- RSI32
- Support-7.6%
- Resistance+0.3%
- Off 52w high-33.4%
- Volume1.2x
- News0.00
- Trendsideways
- 52w range$42–$63
- ATR+6.3%
- Off ATH-80.8%
- FCF yield-9.3%
- Insiders-$4.88M
- MAs0 of 4
- MACD-0.81
Updates with the 15-min delayed price. Not a forecast or investment advice.
![]()
How much does CRISPR Therapeutics stock move?
CRISPR Therapeutics stock performance by year
CRISPR TherapeuticsS&P 500
Falls and rises of 30% or more
8 falls of 30% or more in the last five years, and 7 rises of 30% or more. Today CRISPR Therapeutics is 55.1% below its 5-year high close of $94.14 (Nov 8, 2021) and at its 52-week low close of $42.24 (Nov 13, 2026).
A fall of 30% or moreA rise of 30% or more
Falls of 30% or more
- How many
- 8
- Typical
- -42.0%in about 4 months
- Deepest from a high
- -66.8%Nov 2021 → Apr 2025, not back yet
- Latest
- -31.7%Jul 2026 → Nov 2026, so far, not back yet
Rises of 30% or more
- How many
- 7
- Typical
- +72.9%in about 4 months
- Largest from a low
- +145.5%Apr 2025 → Oct 2025
- Latest
- +34.9%Feb 2026 → Jul 2026
Will CRISPR Therapeutics stock go up?
In the last five years CRISPR Therapeutics closed a month higher 27 times out of 59. That is the past: pretickt does not forecast its direction.
From daily closing prices adjusted for splits and dividends. What happened in the past, not a forecast. For information only, not investment advice.